RNAZ TransCode Therapeutics, Inc. - Common Stock
$3.36
价格 · 八月 19, 2026
截至...的财报数据 八月 14, 2026
RNAZ 股票快照 价格、市值、P/E、EPS、ROE、负债/权益、52周范围
价格
$3.35
市值
—
P/E (TTM)
-0.1
每股收益 (TTM)
$-52.59
营收 (TTM)
—
股息收益率
—
ROE
—
负债/权益
—
52周区间
$3 – $21
RNAZ 股价图表 包含技术指标的日 OHLCV — 平移、缩放和自定义您的视图
Configure
10年表现 收入、净利润、利润率和每股收益趋势
营收与净利润
—
EPS
$-52.59
2020-12-31
→
2025-12-31
自由现金流
—
2021-12-31
→
2023-12-31
利润率
—
估值 P/E、P/S、P/B、EV/EBITDA 比率 — 该股票是昂贵还是便宜？
指标
5年趋势
RNAZ
同行中位数
P/E (TTM)
-0.1
—
盈利能力 毛利率、营业利润率和净利率；股本回报率 (ROE)、资产回报率 (ROA)、投入资本回报率 (ROIC)
指标
5年趋势
RNAZ
同行中位数
财务健康 债务、流动性、偿付能力 — 资产负债表强度
指标
5年趋势
RNAZ
同行中位数
成长 营收、每股收益 (EPS) 和净利润增长：同比、3年复合年增长率 (CAGR)、5年复合年增长率 (CAGR)
指标
5年趋势
RNAZ
同行中位数
资本效率 资产周转率、库存周转率、应收账款周转率
指标
5年趋势
RNAZ
同行中位数
RNAZ 分析师共识 看涨和看跌分析师观点、12个月价格目标、上涨空间
买入
7 位分析师
- 强烈买入 2 28.6%
- 买入 4 57.1%
- 持有 1 14.3%
- 卖出 0 0.0%
- 强烈卖出 0 0.0%
收益历史 每股收益实际值 vs 预估值，惊喜%，达标率，下次财报日期
平均惊喜
74.3%
| 期间 | EPS Actual | EPS 预期 | 惊喜 |
|---|---|---|---|
| 2024年12月31日 | $-150.64 | $-91.68 | -59.0% |
| 2024年9月30日 | $-147.84 | $-461.82 | 314.0% |
| 2024年6月30日 | $-665.28 | $-546.64 | -118.6% |
| 2024年3月31日 | $-498.96 | $-659.74 | 160.8% |
同行比较（GICS 子行业） 关键指标与行业同行对比
| 股票代码 | 市值 | P/E | 营收同比增长 | 净利润率 | ROE | 毛利率 |
|---|---|---|---|---|---|---|
| RNAZ | — | -0.1 | — | — | — | — |
| REVB | — | — | — | — | — | — |
| SILO | $5M | -0.7 | 0.00% | -5863.5% | -75.3% | 38.6% |
| VIVS | $4M | -0.3 | -9.0% | -10567.2% | -294.8% | — |
| CRIS | $13M | -1.7 | -13.4% | -80.3% | 177.9% | — |
| ONCO | $2M | -0.1 | -67.7% | -1721.0% | -129.5% | 77.6% |
| BIAF | — | — | — | — | — | — |
完整基本面 所有年度指标 — 损益表、资产负债表、现金流量表
损益表 15
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| R&D Expense | $13M | $10M | $12M | $10M | $3M | $284.5K | |
| SG&A Expense | $6M | $6M | $7M | $8M | $3M | $442.1K | |
| Operating Expenses | $28M | $16M | $19M | $19M | $6M | $726.6K | |
| Operating Income | $-28M | $-16M | $-19M | $-19M | $-6M | $-726.6K | |
| Interest Expense | · | $26.8K | $55.9K | $32.0K | $95.1K | $394.6K | |
| Interest Income | $79.2K | $684 | $5.3K | $20.4K | $664 | $136 | |
| Other Non-op | $-6M | $-1M | $872.4K | $1M | $-692.3K | $-2M | |
| Pretax Income | $-34M | $-17M | · | · | · | · | |
| Income Tax | $226.1K | $0 | $0 | $0 | $53.1K | $0 | |
| Net Income | $-35M | $-17M | $-19M | $-18M | $-7M | $-2M | |
| EPS (Basic) | $-52.59 | $-1336.63 | $-3419.01 | $-1082.79 | $-0.81 | $-0.51 | |
| EPS (Diluted) | $-52.59 | $-1336.63 | $-3419.01 | $-1082.79 | $-0.81 | $-0.51 | |
| Shares (Basic) | 689,713 | 12,558 | 5,424 | 16,222 | 8,425,880 | 4,636,216 | |
| Shares (Diluted) | 689,713 | 12,558 | 5,424 | 16,222 | 8,425,880 | 4,636,216 | |
| EBITDA | · | · | $-19M | $-19M | $-6M | · |
资产负债表 20
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $18M | $6M | $3M | $5M | $21M | $828.0K | |
| Prepaid Expense | $919.4K | $1M | $2M | $2M | $2M | $3.2K | |
| Current Assets | $22M | $7M | $4M | $7M | $23M | $831.2K | |
| PP&E (Net) | $370.7K | $51.6K | $120.7K | $208.6K | $206.3K | · | |
| PP&E (Gross) | $757.9K | $362.4K | $384.1K | $348.4K | $247.5K | · | |
| Accum. Depreciation | $387.3K | $310.8K | $263.3K | $139.9K | $41.3K | · | |
| Goodwill | $26M | · | · | · | · | · | |
| Intangibles | $114M | · | · | · | · | · | |
| Total Assets | $162M | $7M | $5M | $8M | $23M | $1M | |
| Accounts Payable | $3M | $3M | $3M | $4M | $3M | $369.2K | |
| Current Liabilities | $3M | $3M | $3M | $4M | $3M | $404.9K | |
| Capital Leases | · | · | $38.3K | · | · | · | |
| Deferred Tax | $226.1K | · | · | · | · | · | |
| Total Liabilities | $11M | $9M | $4M | $4M | $3M | $4M | |
| Common Stock | $92 | $4 | $2 | $2 | $1.3K | $464 | |
| Paid-in Capital | $108M | $61M | $48M | $31M | $31M | $65.9K | |
| Retained Earnings | $-98M | $-63M | $-46M | $-28M | $-10M | $-3M | |
| Stockholders' Equity | $10M | $-2M | $2M | $3M | $20M | $-3M | |
| Liabilities + Equity | $162M | $7M | $5M | $8M | $23M | $1M | |
| Shares Outstanding | 916,968 | 36,753 | 19,014 | 16,222 | 12,904,574 | 4,636,216 |
现金流 12
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| D&A | $13.4K | $90.9K | $123.5K | $98.6K | $42.5K | $0 | |
| Stock-based Comp | $485.4K | $2M | $1M | $395.3K | $186.0K | $45.4K | |
| Deferred Tax | $226.1K | · | · | · | · | · | |
| Other Non-cash | · | · | $-688.8K | $1M | $1M | · | |
| Operating Cash Flow | $-20M | $-13M | $-18M | $-16M | $-5M | $-493.0K | |
| CapEx | $6.7K | $21.8K | $35.6K | $100.9K | $254.8K | · | |
| Investing Cash Flow | $-4.4K | $-21.8K | $-35.6K | $-100.9K | $-251.8K | · | |
| Stock Issued | $9M | $16M | $16M | $1M | · | · | |
| Net Stock Activity | · | · | $16M | $1M | · | · | |
| Financing Cash Flow | $32M | $16M | $16M | $6.0K | $26M | $1M | |
| Net Change in Cash | $12M | $3M | $-2M | $-16M | $20M | $623.5K | |
| Free Cash Flow | · | · | $-18M | $-16M | $-6M | · |
盈利能力 2
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| ROA | · | · | -290.7% | -115.1% | -57.0% | · | |
| ROE | · | · | -610.0% | -305.9% | -31.4% | · |
流动性与偿付能力 3
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Current Ratio | · | · | 1.3 | 1.7 | 9.0 | · | |
| Quick Ratio | · | · | 0.8 | 1.1 | 8.2 | · | |
| Interest Coverage | · | · | -347.4 | · | -64.7 | · |
估值 (TTM) 8
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Net Income TTM | $-35M | $-17M | $-19M | $-18M | $-7M | · | |
| Market Cap | · | · | $3.83B | $6.46T | $24.23T | · | |
| P/E | -0.1 | -0.1 | -1.8 | -459.4 | -2317985.2 | · | |
| P/B | · | · | 2332.0 | 1992144.6 | 1187453.7 | · | |
| P / Tangible Book | · | · | 2332.0 | 1992144.6 | 1187453.7 | · | |
| P / Cash Flow | · | · | -211.7 | -409575.3 | -4600293.2 | · | |
| P / FCF | · | · | -211.3 | -406969.7 | -4387995.2 | · | |
| Earnings Yield | -770.0% | -1416.5% | -56.1% | -0.22% | 0.00% | · |
损益表 15
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $4M | $5M | $5M | $3M | $3M | $2M | $4M | $1M | $3M | $2M | $3M | $3M | $3M | $3M | $3M | $3M | |
| SG&A Expense | $3M | $2M | $2M | $1M | $2M | $951.7K | $1M | $938.0K | $2M | $2M | $734.0K | $2M | $2M | $2M | $3M | $2M | |
| Operating Expenses | $7M | $18M | $16M | $5M | $4M | $3M | $5M | $2M | $5M | $3M | $4M | $5M | $5M | $5M | $5M | $5M | |
| Operating Income | $-7M | $-18M | $-16M | $-5M | $-4M | $-3M | $-5M | $-2M | $-5M | $-3M | $-4M | $-5M | $-5M | $-5M | $-5M | $-5M | |
| Interest Expense | · | · | · | · | · | $114 | · | $10.8K | $4.5K | $9.7K | $17.3K | $17.3K | $7.8K | $13.4K | · | · | |
| Interest Income | $52.2K | $91.9K | $78.8K | $147 | $148 | $146 | $159 | $179 | $178 | $168 | $138 | $131 | $246 | $4.8K | $9.6K | $9.0K | |
| Other Non-op | $39.7K | $201.3K | $3M | $-294.9K | $-55.4K | $-9M | $-823.6K | $-156.0K | $-76.9K | $-37.8K | $10.0K | $10.3K | $781.3K | $70.8K | $361.4K | $664.0K | |
| Pretax Income | $-7M | $-18M | · | · | $-4M | $-12M | · | · | · | · | · | · | · | · | · | · | |
| Income Tax | · | · | $226.1K | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-7M | $-18M | $-13M | $-5M | $-4M | $-12M | $-6M | $-2M | $-5M | $-3M | $-4M | $-5M | $-4M | $-5M | $-5M | $-4M | |
| EPS (Basic) | $-7.17 | $-21.28 | $-39.13 | $-5.82 | $-5.13 | $-70.16 | $-488.99 | $-146.06 | $-680.23 | $-21.35 | $-2969.12 | $-48.44 | $-142.38 | $-259.07 | $-1068.71 | $-6.61 | |
| EPS (Diluted) | $-7.17 | $-21.28 | $-39.13 | $-5.82 | $-5.13 | $-70.16 | $-488.99 | $-146.06 | $-680.23 | $-21.35 | $-2969.12 | $-48.44 | $-142.38 | $-259.07 | $-1068.71 | $-6.61 | |
| Shares (Basic) | 957,191 | 916,968 | -5,800,941 | 833,683 | 833,653 | 172,262 | -166,797 | 15,893 | 7,631 | 155,831 | -153,076 | 109,413 | 30,494 | 18,593 | -14,258,736 | 648,862 | |
| Shares (Diluted) | 957,191 | 916,968 | -5,800,941 | 833,683 | 833,653 | 172,262 | -166,797 | 15,893 | 7,631 | 155,831 | -153,076 | 109,413 | 30,494 | 18,593 | -14,258,736 | 648,862 | |
| EBITDA | $-7M | $-18M | · | $-5M | $-4M | $-3M | · | $-2M | $-5M | $-3M | · | $-5M | $-5M | $-5M | · | $-5M |
资产负债表 20
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $8M | $13M | $18M | $3M | $7M | $12M | $6M | $2M | $3M | $5M | $3M | $7M | $4M | $2M | $5M | $9M | |
| Prepaid Expense | $2M | $2M | $919.4K | $2M | $690.8K | $1M | $1M | $2M | $1M | $2M | $2M | $2M | $1M | $3M | $2M | $2M | |
| Current Assets | $11M | $17M | $22M | $5M | $8M | $13M | $7M | $4M | $4M | $7M | $4M | $9M | $5M | $4M | $7M | $12M | |
| PP&E (Net) | $322.8K | $346.7K | $370.7K | $19.9K | $24.7K | $38.1K | $51.6K | $61.4K | $64.6K | $92.4K | $120.7K | $152.4K | $179.0K | $191.8K | $208.6K | $209.9K | |
| PP&E (Gross) | $757.9K | $757.9K | $757.9K | $362.4K | $362.4K | $362.4K | $362.4K | $405.3K | $392.4K | $387.9K | $384.1K | $384.1K | $379.4K | $361.3K | $348.4K | $320.2K | |
| Accum. Depreciation | $435.1K | $411.2K | $387.3K | $342.5K | $337.7K | $324.3K | $310.8K | $343.9K | $327.9K | $295.5K | $263.3K | $231.7K | $200.5K | $169.5K | $139.9K | $110.4K | |
| Goodwill | $26M | $26M | $26M | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Intangibles | $114M | $114M | $114M | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Total Assets | $151M | $157M | $162M | $5M | $8M | $13M | $7M | $4M | $5M | $7M | $5M | $10M | $6M | $6M | $8M | $12M | |
| Accounts Payable | $5M | $5M | $3M | $3M | $2M | $3M | $3M | $2M | $3M | $2M | $3M | $5M | $3M | $5M | $4M | $4M | |
| Current Liabilities | $5M | $5M | $3M | $3M | $2M | $3M | $3M | $2M | $4M | $3M | $3M | $6M | $4M | $5M | $4M | $4M | |
| Capital Leases | · | · | · | · | · | · | · | · | · | · | $38.3K | $189.8K | $265.7K | $377.8K | · | · | |
| Deferred Tax | $457.7K | $457.4K | $226.1K | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Total Liabilities | $13M | $13M | $11M | $4M | $2M | $3M | $9M | $2M | $4M | $3M | $4M | $6M | $4M | $6M | $4M | $4M | |
| Common Stock | $101 | $92 | $92 | $84 | $84 | $2.3K | $4 | $1.7K | $727 | $581 | $2 | $1.1K | $195 | $1.6K | $2 | $1.3K | |
| Paid-in Capital | $95M | $117M | $108M | $86M | $86M | $86M | $61M | $59M | $56M | $54M | $48M | $47M | $39M | $32M | $31M | $31M | |
| Retained Earnings | $-122M | $-116M | $-98M | $-84M | $-80M | $-75M | $-63M | $-57M | $-55M | $-50M | $-46M | $-42M | $-37M | $-33M | $-28M | $-23M | |
| Stockholders' Equity | $-28M | $1M | $10M | $1M | $6M | $10M | $-2M | $2M | $1M | $5M | $2M | $4M | $2M | $-236.8K | $3M | $8M | |
| Liabilities + Equity | $151M | $157M | $162M | $5M | $8M | $13M | $7M | $4M | $5M | $7M | $5M | $10M | $6M | $6M | $8M | $12M | |
| Shares Outstanding | 1,011,595 | 916,968 | 916,968 | 833,683 | 833,683 | 23,341,336 | 36,753 | 17,265,658 | 7,265,658 | 5,808,053 | 19,014 | 10,687,724 | 1,950,674 | 15,823,534 | 16,222 | 12,977,234 |
现金流 12
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $23.9K | $23.9K | $44.8K | $4.8K | $13.4K | $13.4K | $10.3K | $16.0K | $32.4K | $32.2K | $31.7K | $31.2K | $31.0K | $29.6K | $29.5K | $24.8K | |
| Stock-based Comp | · | · | $61.9K | $134.3K | $131.5K | $157.7K | $168.8K | $204.5K | $1M | $183.2K | $310.3K | $392.3K | $175.5K | $158.8K | $130.6K | $105.6K | |
| Deferred Tax | $300 | $231.3K | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Other Non-cash | · | $13M | · | · | · | $9M | · | · | · | $-825.7K | · | · | · | $115.0K | · | · | |
| Operating Cash Flow | $-5M | $-5M | $-8M | $-4M | $-4M | $-3M | $-3M | $-4M | $-2M | $-4M | $-6M | $-4M | $-4M | $-5M | $-4M | $-4M | |
| CapEx | · | · | · | · | · | · | $500 | $12.9K | $4.6K | $3.8K | $0 | $4.6K | $18.1K | $12.9K | $28.2K | $0 | |
| Investing Cash Flow | · | · | · | · | · | · | $-500 | $-12.9K | $-4.6K | $-3.8K | $0 | $-4.6K | $-18.1K | $-12.9K | $-28.2K | $0 | |
| Stock Issued | · | · | $1 | $0 | $0 | $9M | $7M | $2M | $785.2K | $6M | $978.2K | $7M | $6M | $1M | · | · | |
| Net Stock Activity | · | · | · | · | · | $9M | · | · | · | $6M | · | · | · | $1M | · | · | |
| Financing Cash Flow | · | · | $23M | $-455.7K | $0 | $9M | $7M | $2M | $785.2K | $6M | $978.2K | $7M | $6M | $1M | $225.8K | $-225.8K | |
| Net Change in Cash | $-4M | $-5M | $15M | $-5M | $-4M | $6M | $4M | $-1M | $-2M | $2M | $-5M | $4M | $2M | $-3M | $-4M | $-5M | |
| Free Cash Flow | · | · | · | · | · | · | · | · | · | $-4M | · | · | · | $-5M | · | · |
盈利能力 2
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -8.5% | -20.9% | · | -106.0% | -65.3% | -128.7% | · | -41.4% | -97.0% | · | · | -47.6% | -43.3% | -39.4% | · | -22.9% | |
| ROE | 62.6% | -308.1% | · | -315.5% | -114.5% | -240.4% | · | -74.5% | -304.0% | · | · | -83.6% | -59.8% | -57.5% | · | -27.3% |
流动性与偿付能力 3
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.0 | 3.1 | · | 1.6 | 5.3 | 5.2 | · | 1.6 | 1.3 | · | · | 1.7 | 1.4 | 0.8 | · | 3.1 | |
| Quick Ratio | 1.6 | 2.4 | · | 1.0 | 4.7 | 4.6 | · | 0.8 | 1.0 | · | · | 1.3 | 1.0 | 0.3 | · | 2.3 | |
| Interest Coverage | · | · | · | · | · | -27817.4 | · | -200.6 | -1141.0 | -338.9 | · | · | · | · | · | · |
估值 (TTM) 8
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-34M | $-39M | · | $-24M | $-24M | $-23M | · | $-16M | $-18M | $-18M | · | $-19M | $-18M | $-17M | · | $-15M | |
| Market Cap | $6M | $8M | · | $9M | $7M | $324M | · | $9.11B | $6.75B | · | · | $198.69B | $165.82B | $3.97T | · | $10.55T | |
| P/E | -0.2 | -0.1 | · | -0.1 | -0.0 | -0.0 | · | -0.6 | -1.0 | -1.3 | · | -40.7 | -204.7 | -917.4 | · | -56941.2 | |
| P/B | -0.2 | 6.3 | · | 6.3 | 1.1 | 31.4 | · | 5513.6 | 5102.6 | · | · | 44752.0 | 79247.7 | -16745499.6 | · | 1279936.5 | |
| P / Tangible Book | · | · | · | 6.3 | 1.1 | 31.4 | · | 5513.6 | 5102.6 | · | · | 44752.0 | 79247.7 | · | · | 1279936.5 | |
| P / Cash Flow | · | -1.6 | · | · | · | -104.5 | · | · | · | · | · | · | · | -878510.1 | · | · | |
| P / FCF | · | · | · | · | · | · | · | · | · | · | · | · | · | -876007.2 | · | · | |
| Earnings Yield | -634.5% | -1189.2% | · | -1483.9% | -10691.4% | -6133.8% | · | -169.8% | -96.1% | -74.7% | · | -2.5% | -0.49% | -0.11% | · | 0.00% |
财务报表 损益表、资产负债表、现金流量表 — 年度，近5年
损益表
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 净收入 | $-35M | $-17M | $-19M | $-18M | $-7M |
| 稀释后每股收益 (EPS) | $-52.59 | $-1336.63 | $-3419.01 | $-1082.79 | $-0.81 |
资产负债表
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 流动比率 | — | — | 1.3 | 1.7 | 9.0 |
| 速动比率 | — | — | 0.8 | 1.1 | 8.2 |
现金流
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 自由现金流 | — | — | $-18M | $-16M | $-6M |
我的指标 您的个人关注列表 — 来自完整基本面的选定行
📊
选择对您重要的指标 — 点击上方完整基本面中任意行的 ➕。
您的选择已保存，并会跟随您浏览所有股票。
机构持有人 (13F) 9 家申报者 · $218K 总计 · 截至 2026年6月30日
在其季度SEC表格13F中报告持有此股票的机构。仅限多头头寸；单个申报人可能因单独的期权腿而出现两次。 大的抵消性看跌/看涨腿通常反映做市或对冲库存，而非方向性判断。
机构活动 — Q2 2026 与上一季度对比
| 新仓位 | 已退出持仓 | 增加 | 减少 | 净股数变动 |
|---|---|---|---|---|
| 5 (+3 与上一季度对比) | 2 (0 与上一季度对比) | 1 (-1 与上一季度对比) | 1 (0 与上一季度对比) | +18K |
与Q1 2026对比。 SEC 13F表格的提交截止日期是季度末后45天，外加少量延迟提交的缓冲期——在此窗口期内的季度将被跳过，优先显示最近一个已完整报告的季度对。
| 机构 | 价值 | 股份 | % 已追踪的13F | 类型 |
|---|---|---|---|---|
| Yorkville Advisors Global, LP | $121958 | 19639 | 56.05% | 股份 |
| VANGUARD CAPITAL MANAGEMENT LLC | $40644 | 6545 | 18.68% | 股份 |
| VANGUARD FIDUCIARY TRUST CO | $18518 | 2982 | 8.51% | 股份 |
| UBS Group AG | $17934 | 2888 | 8.24% | 股份 |
| MERCER GLOBAL ADVISORS INC /ADV | $9532 | 1535 | 4.38% | 股份 |
| FMR LLC | $4384 | 706 | 2.01% | 股份 |
| Tower Research Capital LLC (TRC) | $4204 | 677 | 1.93% | 股份 |
| WELLS FARGO & COMPANY/MN | $342 | 55 | 0.16% | 股份 |
| SBI Securities Co., Ltd. | $75 | 12 | 0.03% | 股份 |
公司内部人士 6 位内幕人士 · 3 位高管 · 5 位董事
| 内部人士 | 角色 | 上次活动 | 持股数量 | 买入 12个月 | 卖出 12个月 | 净额 12个月 |
|---|---|---|---|---|---|---|
| Thomas A Fitzgerald | Interim CEO, CFO | 2024年6月14日 A | 56318 | 0 | 0 | $0 |
| Robert Michael Dudley | Chief Executive Officer | 2023年9月28日 P | 180262 | 0 | 0 | $0 |
| Zdravka Medarova | Chief Technology Officer | 2022年12月12日 A | — | 0 | 0 | $0 |
| Erik Manting | 董事 | 2024年6月14日 A | — | 0 | 0 | $0 |
| Philippe Calais | 董事 | 2024年6月14日 A | — | 0 | 0 | $0 |
| Magda Marquet | 董事 | 2024年6月14日 A | — | 0 | 0 | $0 |
来自SEC表格3/4/5申报的内部人士；净额=仅公开市场买卖
激进投资者及 5%+ 股东 5 持仓
提交了 SEC Schedule 13D 的投资者 — 持有超过 5% 的受益所有权，意图影响发行人（激进股东持股、董事会活动、并购）。每一行显示该申报人持仓的最新已知状态。
| 申报人 | 已申报 | 持股 | 状态 | 目的 | 申报 |
|---|---|---|---|---|---|
| DEFJ, LLC, CK Life Sciences Int'l., (Holdings) Inc. ×4 申报 | 2026年8月3日 | 83.90% | 修订 | — | SEC |
| CK Life Sciences Int'l., (Holdings) Inc., DEFJ, LLC ×2 申报 | 2025年10月28日 | 9.10% | 修订 | — | SEC |
| Thomas Joseph Tracy | 2025年3月20日 | 5.00% | 初始申报 | 被动投资 | SEC |
| Thomas A. Fitzgerald (2) | 2024年6月21日 | — | 初始申报 | — | SEC |
| Robert Michael Dudley (2) ×3 申报 | 2023年10月10日 | — | 初始申报 | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF持仓 由 1 只交易所交易基金持有
权重仅反映直接股权持仓（N-PORT）；杠杆基金或基于衍生品的基金可能持有未显示的额外掉期敞口。
| 基金 | 权重 | 单位 | 截至 | 来源 |
|---|---|---|---|---|
| VXF · VANGUARD INDEX FUNDS | 0.00% | 6545 SH | 2026年8月8日 | 每日 |